Coronavirus: A New Type of Vaccine Using RNA Could Help Defeat COVID-19
Author: Sanjay Mishra.; Robert Carnahan.
Source: Volume 21, Number 04, May/June 2020 , pp.57-58(2)
< previous article |next article > |return to table of contents
Abstract:
The fast-spreading COVID-19 has already infected more than one and a half million worldwide, and has killed over 90,000 patients. There is an urgent need for a vaccine to prevent it from infecting and killing millions more. But traditional vaccine development takes, on average, 16 years. Two immunologists from Vanderbilt University seek to answer the question, “how can scientists quickly develop a vaccine for SARS-CoV-2?” This article is published under a Creative Commons license from “The Conversation.” Correctional Health Care Report’s coverage of Covid-19 is being made available at no charge. This article can be accessed free at https://www.civicresearchinstitute.com/pdfs/CHC-2104-04-Vaccine.pdfKeywords: SARS-CoV-2 Vaccine; mRNA Vaccine; RNA-based Antibodies
Affiliations:
1: Vanderbilt University; 2: Vanderbilt University.